Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?

Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?

Authors

  • Hala M. Elsadek Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
  • Radwa O. M. Kamel Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
  • Marwa Abdallah Elsaid Clinical Pathology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
  • Rasha Muhammad Rashed Ophthalmology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
  • Mona S. Ali Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt

Keywords:

Osteopontin, psoriasis, ocular comorbidity, blepharitis, dry eye syndrome

Abstract

Introduction: Psoriasis is a chronic inflammatory disease affecting 2%-3% of the global population via immune-mediated mechanisms. Osteopontin plays a crucial role in T-helper 1 and T-helper 17-mediated illnesses, including psoriasis. Ocular complications in psoriasis have been reported and their assessment is of importance. Osteopontin is normally expressed constitutively in ocular structures and is linked to ocular homeostasis.

Objective: This study aimed to clarify the role of osteopontin (OPN) in psoriasis (PS) and its correlation with disease severity and ocular manifestations.  

Methods: A case-control study involving 40 psoriatic patients and an equal number of age and sex-matched healthy subjects was conducted. We used the psoriasis area severity index (PASI) to assess disease severity and performed a comprehensive ophthalmological examination. Additionally, we measured serum osteopontin levels using Enzyme-Linked Immunosorbent Assay (ELISA) in both groups.

Results: A significant elevation in serum OPN levels in psoriatic patients compared to controls was found (P=0.00). Furthermore, there was a highly significant positive correlation between serum OPN levels and patient age, disease duration, and PASI scores. Notably, a higher prevalence of ocular complications, including blepharitis, corneal affection, conjunctivitis, keratoconjunctivitis sicca, and cataract, in psoriatic patients compared to controls was observed. Importantly, significant associations between serum OPN levels and the presence of cataracts and intraocular pressure (IOP) were identified. Additionally, significant correlations between serum OPN levels and measures of visual acuity and ocular surface health were found.

Conclusions: Osteopontin is considered a marker of psoriasis severity and is associated with ocular comorbidities in psoriasis.

Author Biography

Hala M. Elsadek, Dermatology and Venereology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt

None

References

Abd-ElAzim SM, El-Rifaie A-E, Rashed LA, Kamel HA-E. Detection of Cyclophilin D in Psoriasis and its Correlation with Disease Severity Egy J Med Res. 2022;3(1):291-302. DOI:10.21608/ejmr.2022.222586.

Daugaard C, Iversen L, Hjuler KF. Comorbidity in Adult Psoriasis: Considerations for the Clinician. Psoriasis (Auckl). 2022;12:139-50. DOI:10.2147/ptt.S328572.

Kolli SR, Boda N, Reddy EA. Ocular manifestations in psoriasis. . Nation J Med Dent Res 2016;4:101-4.

Mashal ZR, Elgamal EEA, Zaky MS, Elsaie ML. Dermoscopic Features of Psoriatic Nails and Their Correlation to Disease Severity. Dermatol Res Pract. 2023;2023:4653177. DOI:10.1155/2023/4653177.

Orsini C, Trovato E, Cortonesi G, et al. Line-field confocal optical coherence tomography: New insights for psoriasis treatment monitoring. J Eur Acad Dermatol Venereol. 2024;38(2):325-31. DOI:10.1111/jdv.19568.

Sanchez LR, Borriello L, Entenberg D, Condeelis JS, Oktay MH, Karagiannis GS. The emerging roles of macrophages in cancer metastasis and response to chemotherapy. J Leukoc Biol. 2019;106(2):259-74. DOI:10.1002/jlb.Mr0218-056rr.

Bartosińska J, Przepiórka-Kosińska J, Sarecka-Hujar B, et al. Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients. J Clin Med. 2021;10(4). DOI:10.3390/jcm10040755.

Kim J, Ahn M, Choi Y, et al. Osteopontin is a biomarker for early autoimmune uveoretinitis. Neural Regen Res. 2022;17(7):1604-8. DOI:10.4103/1673-5374.330614.

Naldi L. Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies. Clin Dermatol. 2010;28(1):67-72. DOI:10.1016/j.clindermatol.2009.03.001.

Omar SS, Helaly HA. Prevalence of ocular findings in a sample of Egyptian patients with psoriasis. Indian J Dermatol Venereol Leprol. 2018;84(1):34-38. DOI:10.4103/ijdvl.IJDVL_1239_15.

Przepiórka-Kosińska JM, Bartosińska J, Raczkiewicz D, et al. Serum concentration of osteopontin and interleukin 17 in psoriatic patients. Adv Clin Exp Med. 2020;29(2):203-8. DOI:10.17219/acem/112604.

Abdou AG, El Farargy S, Seleit I, Antar AG, Elhefny M, Elnaidany NF. Osteopontin expression in chronic plaque psoriasis: an association with the severity of disease. Anal Quant Cytol Histol. 2012;34(2):79-85.

Buommino E, Tufano MA, Balato N, et al. Osteopontin: a new emerging role in psoriasis. Arch Dermatol Res. 2009;301(6):397-404. DOI:10.1007/s00403-009-0939-5.

Kahles F, Findeisen HM, Bruemmer D. Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab. 2014;3(4):384-93. DOI:10.1016/j.molmet.2014.03.004.

Kılınç C, Korkmaz S, Özgün G, Fiçicioğlu S, Pişkin S. Serum osteopontin levels in patients with psoriasis vulgaris and its relation with oxidative stress. Türkderm Türk deri hastalıkları ve frengi arşivi. 2023;57(2):61-5.

Kadry D, Hegazy RA, Rashed L. Osteopontin and adiponectin: how far are they related in the complexity of psoriasis? Arch Dermatol Res. 2013;305(10):939-44. DOI:10.1007/s00403-013-1392-z.

Abdel-Mawla MY, El-Kasheshy KA, Ghonemy S, Al Balat W, Elsayed AA. Role of Osteopontin in Psoriasis: An Immunohistochemical Study. Indian J Dermatol. 2016;61(3):301-7. DOI:10.4103/0019-5154.182434.

Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J Am Acad Dermatol. 2009;60(2):225-30. DOI:10.1016/j.jaad.2008.09.046.

Kharolia A, Parija S, Moharana B, Sirka CS, Sahu SK. Ocular manifestations in moderate-to-severe psoriasis in India: A prospective observational study. Indian J Ophthalmol. 2022;70(9):3328-32. DOI:10.4103/ijo.IJO_551_22.

Kilic B, Dogan U, Parlak AH, et al. Ocular findings in patients with psoriasis. Int J Dermatol. 2013;52(5):554-9. DOI:10.1111/j.1365-4632.2011.05424.x.

Cruz N, Brandão LS, Cruz S, Cruz S, Pires CAA, Carneiro FRO. Ocular manifestations of psoriasis. Arq Bras Oftalmol. 2018;81(3):219-25. DOI:10.5935/0004-2749.20180044.

Ghalamkarpour F, Baradaran-Rafii A, Sadoughi MM, et al. Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study. J Dermatolog Treat. 2020;31(1):27-32. DOI:10.1080/09546634.2019.1577947.

Ruggiero A, Fabbrocini G, Cacciapuoti S, Cinelli E, Gallo L, Megna M. Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis. J Clin Med. 2021;10(5). DOI:10.3390/jcm10051031.

Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009;145(4):379-82. DOI:10.1001/archdermatol.2009.48.

Demerdjieva Z, Mazhdrakova I, Tsankov N. Ocular changes in patients with psoriasis. Clin Dermatol. 2019;37(6):663-7. DOI:10.1016/j.clindermatol.2019.07.029.

Erbagci I, Erbagci Z, Gungor K, Bekir N. Ocular anterior segment pathologies and tear film changes in patients with psoriasis vulgaris. Acta Med Okayama. 2003;57(6):299-303. DOI:10.18926/amo/32810.

Zengin N, Tol H, Balevi S, Gündüz K, Okudan S, Endoğru H. Tear film and meibomian gland functions in psoriasis. Acta Ophthalmol Scand. 1996;74(4):358-60. DOI:10.1111/j.1600-0420.1996.tb00708.x.

Balamurugan MS, Somanath A. Commentary: A clinician should know about systemic psoriasis and eye. Indian J Ophthalmol. 2022 Sep;70(9):3332-3334. DOI: 10.4103/ijo.IJO_1547_22. PMID: 36018115; PMCID: PMC9675510.

Lee CY, Chen HC, Lin HW, et al. Increased risk of keratopathy after psoriasis: A nationwide population-based study. PLoS One. 2018;13(7):e0201285. DOI:10.1371/journal.pone.0201285.

Rajguru JP, Maya D, Kumar D, Suri P, Bhardwaj S, Patel ND. Update on psoriasis: A review. J Family Med Prim Care. 2020;9(1):20-4. DOI:10.4103/jfmpc.jfmpc_689_19.

Aragona E, Rania L, Postorino EI, et al. Tear film and ocular surface assessment in psoriasis. Br J Ophthalmol. 2018;102(3):302-8. DOI:10.1136/bjophthalmol-2017-310307.

Saika S, Shirai K, Yamanaka O, et al. Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium. Lab Invest. 2007;87(2):130-8. DOI:10.1038/labinvest.3700508.

Saika S, Miyamoto T, Ishida I, Ohnishi Y, Ooshima A. Osteopontin: a component of matrix in capsular opacification and subcapsular cataract. Invest Ophthalmol Vis Sci. 2003;44(4):1622-8. DOI:10.1167/iovs.02-0873.

Xue W, Comes N, Borrás T. Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors. Invest Ophthalmol Vis Sci. 2007;48(7):3184-94. DOI:10.1167/iovs.06-1403.

Chowdhury UR, Madden BJ, Charlesworth MC, Fautsch MP. Proteome analysis of human aqueous humor. Invest Ophthalmol Vis Sci. 2010;51(10):4921-31. DOI:10.1167/iovs.10-5531.

Dogru M, Kojima T, Simsek C, Tsubota K. Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease. Invest Ophthalmol Vis Sci. 2018;59(14):Des163-des8. DOI:10.1167/iovs.17-23402.

Downloads

Published

2024-10-30

How to Cite

1.
Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?. Dermatol Pract Concept [Internet]. 2024 Oct. 30 [cited 2024 Dec. 3];14(4):e2024226. Available from: https://dpcj.org/index.php/dpc/article/view/4289

Share